The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.

The Danish American who doubted Covid shots is meant to lead drug regulation – but has focused on vaccines ...

The recent wave of pharmaceutical tragedies in Sri Lanka, as well as some others that have occurred regularly in the past, ...

The revised EU pharmaceutical policy maintains eight-year data protection but reduces market protection to one year, ...

Ipsen gains exclusive global rights, outside of Greater China, for development, manufacturing and commercialization of SIM0613, a LRRC15-targeting antibody-drug conjugateSIM0613 is optimally designed ...

Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the pharmaceutical industry's impact on healthcare.

The EU is set to introduce new incentives to stimulate pharmaceutical R&D, particularly for new antibiotics and treatments for rare diseases, after lawmakers reached a provisional agreement on ...

Povorcitinib is a selective oral small-molecule JAK1 inhibitor, with compound and use patents in certain countries/regions in the Territory. Currently, povorcitinib is in Phase 3 clinical trials for ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Introduction: Non-clinical immunogenicity yields valuable insights into pharmacokinetics, efficacy, and safety. Given the complex nature of ADC therapeutics, early detection of anti-drug antibodies ...

Photo courtesy of starline on Freepik. Opinions expressed by Digital Journal contributors are their own. Santosh Kesarpu has established expertise in complex generic formulation, applying rigorous ...

Prescription drug prices in the United States continue to be higher — often much higher — than in other countries. One reason is the misuse of patents by drug manufacturers. A key area of concern is ...